Orexo provides information about its new proprietary drug delivery platform – amorphOX[TM]
· amorphOXTM is a novel and inventive drug delivery platform that can be used to develop highly differentiated products with various active ingredients and administration routes · The amorphOXTM platform provides for excellent chemical and physical stability, commonly a significant problem for amorphous drug compositions · Development of products based on amorphOXTM will be conducted by Orexo or in partnership with other pharmaceutical companies Uppsala, Sweden – November 26, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today provides information about its new